Abiomed Inc. ABMD recently announced that its Impella 2.5 heart pump has received FDA Pre-Market Approval (PMA) for use in high risk percutaneous coronary intervention (PCI) procedures. Notably, ...
Morning Overview on MSN
The FDA flagged a recalled heart pump that can seriously injure or kill patients
Patients relying on a temporary heart pump to stay alive face a direct threat: the FDA classified a recall of Abiomed’s ...
PHILADELPHIA -- The Impella mechanical support device, frequently used in patients in cardiogenic shock who are undergoing percutaneous coronary interventions, was more expensive than intra-aortic ...
DANVERS, Mass.--(BUSINESS WIRE)--Data from more than 1,000 patients presented during the virtual 2020 Society for Cardiovascular Angiography & Interventions (SCAI) Scientific Sessions demonstrates ...
WASHINGTON, DC—A protocol focusing on early use of the Impella ventricular support device (Abiomed) in patients with acute MI complicated by cardiogenic shock may help lower the stubbornly high ...
Compared with no added support, use of the Impella percutaneous left ventricular assist device (Abiomed) in patients undergoing high-risk nonemergent PCI is associated with more periprocedural MI ...
CINCINNATI, Dec. 13, 2024 /PRNewswire/ -- In a groundbreaking achievement for pediatric heart care, the FDA has expanded the labeling of Johnson & Johnson MedTech's Impella Support System to include ...
In October 2019, the first U.S. patients were successfully treated by cardiac surgeons at Cleveland Clinic, Hackensack Meridian Health and Cedars-Sinai Medical Center. Since then, more than 120 ...
DANVERS, Mass.--(BUSINESS WIRE)--Abiomed (Nasdaq: ABMD) announces the first three patients in the world have been treated with Impella RP Flex with SmartAssist, Abiomed’s newest heart pump for ...
An international trial of the Impella heart pump in patients with ST elevation myocardial infarction (STEMI) and cardiogenic shock has been stopped by the sponsor Abiomed, Inc. The termination ...
A new national study finds that use of the Impella circulatory support device is associated with higher rates of death and major bleeding than a common alternative, especially among patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results